Records anticoagulant treatment history in patients with heart rhythm, clot, or valve conditions
Collects data on adults taking blood-thinning drugs for atrial fibrillation, clots, or heart valve problems.
Plain-language title generated from the registry record
Registry title: START-Register: Survey on Anticoagulated Patients Register
Key facts
- Where
- Bologna, ItalySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry follows adults who are starting long-term blood-thinning (anticoagulant) treatment, or switching from a vitamin K antagonist to a newer oral anticoagulant, with treatment expected to last at least 3 months.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Atrial fibrillation, venous thromboembolism, or heart valve disease or prosthesis, needing anticoagulant treatment expected to last at least 3 months.
- Earlier treatment
- Patients start an anticoagulant, or switch from a vitamin K antagonist (VKA) drug to a direct oral anticoagulant (DOAC).
Main reasons for not taking part
- Under 18 years
- Not willing to sign informed consent
Read by machine on 12 November 2026.
Where in Italy
- S. Orsola-Malpighi University hospitalBologna, ItalyContact: Emilia AntonucciTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- GUALTIERO PALARETI
- Trial code
- NCT02219984
- Record updated
- 2 February 2023
- Original description
This is a phase 4 cohort prospective, open, national, multicentre study that collects data on history of patients treated chronically with anticoagulant drugs, including the novel direct oral anticoagulants (DOACs). The Registry is designed solely for observational purposes and is not intended to have any influence on the treatment of the single patients included.Read full original descriptionShow less
Phase 4 Study on Clinical History of Patients Who Start a Chronic Anticoagulant Treatment
This is a phase 4 cohort prospective, open, national, multicentre study that collects data on history of patients treated chronically with anticoagulant drugs, including the novel direct oral anticoagulants (DOACs). The Registry is designed solely for observational purposes and is not intended to have any influence on the treatment of the single patients included.
Patients are included when they start the anticoagulant treatment, whatever the drug used, or when they shift from a vitamin K antagonist (VKA) drug to one of the novel direct oral anticoagulants, provided that the therapy is expected to last at least 3 months.
The general aims of the study are to provide a better evaluation of efficacy and safety of different treatment options, and to improve our understanding of the risks/benefits of the various anticoagulant drugs and the different therapy options.
The Registry is open to the participation of clinical centres or individual professionals (now called Participants) that are involved with management of anticoagulated patients.
Inclusion: age >= 18 years.
Exclusion: < 18 years; not willing to sign informed consent.